Viridian Therapeutics, Inc.\DE (VRDN) EBITDA Margin Growth (5y) (2018 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.11 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Jun 30, 2025 | -13.86 Mn |
| Mar 31, 2025 | -12.94 Mn |
| Sep 30, 2024 | -9.62 Mn |
| Jun 30, 2024 | -10.00 Mn |
| Mar 31, 2024 | -7.45 Mn |
| Dec 31, 2023 | -9.71 Mn |
| Sep 30, 2023 | -7.02 Mn |
| Jun 30, 2023 | -8.19 Mn |
| Mar 31, 2023 | -7.39 Mn |
| Dec 31, 2022 | -4.62 Mn |
| Sep 30, 2022 | -213,140.00 |
| Jun 30, 2022 | -1.05 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | -1.24 Mn |
| Sep 30, 2021 | -635,908.00 |
| Jun 30, 2021 | -134,178.00 |
| Mar 31, 2021 | -88,987.00 |
| Dec 31, 2020 | -16.73 Mn |